System of fixed prices for the sale of prescription-only medicinal products for human use by phar-macies as a measure having equivalent effect to a quantitative restriction on imports. Case comment to the Judgment of the Court of Justice of the European Union of 19 October 2016 in case C 148/15: Deutsche Parkinson Vereinigung eV v. Zentrale zur Bekämpfung unlauteren Wettbewerbs eV

Authors

Tomasz Kaźmierczak, Doktorant w Zakładzie Prawa Konkurencji Polskiej Akademii Nauk; prawnik w KRK Kieszkowska Rutkowska KolasińskiFollow

Recommended Citation

Kaźmierczak, T. (2016). System of fixed prices for the sale of prescription-only medicinal products for human use by phar-macies as a measure having equivalent effect to a quantitative restriction on imports. Case comment to the Judgment of the Court of Justice of the European Union of 19 October 2016 in case C 148/15: Deutsche Parkinson Vereinigung eV v. Zentrale zur Bekämpfung unlauteren Wettbewerbs eV. internetowy Kwartalnik Antymonopolowy i Regulacyjny (internet Quarterly on Antitrust and Regulation), 5(8), 122-126. https://doi.org/10.7172/2299-5749.IKAR.8.5.10

First Page

122

Last Page

126

Page Count

4

DOI

10.7172/2299-5749.IKAR.8.5.10

Publisher

University of Warsaw